MetLife Investment Management’s NxStage Medical Inc. NXTM Stock Holding History

MetLife Investment Management’s Portfolio NXTM Stock Details NXTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-30,508	Closed	-$873K	–	2621
2018 Q4	$873K	Hold	30,508	–	–	0.01%	1074
2018 Q3	$851K	Hold	30,508	–	–	0.01%	1215
2018 Q2	$851K	Hold	30,508	–	–	0.01%	1097
2018 Q1	$758K	Hold	30,508	–	–	0.01%	1136
2017 Q4	$739K	Buy	+30,508	New	+$804K	0.01%	1175

Other funds holding NXTM

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

MetLife Investment Management's NXTM Position: Q1 2019 in Review

MetLife Investment Management sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 30,508 shares — an estimated $873K sold.

MetLife Investment Management first reported a position in NXTM in Q4 2017 and held it in 5 quarters. The position peaked at $873K in Q4 2018. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.

MetLife Investment Management reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
MetLife Investment Management sold 30,508 NxStage Medical Inc. shares in Q1 2019, an estimated $873K.
MetLife Investment Management first reported a position in NxStage Medical Inc. in Q4 2017 and held it in 5 quarters.
MetLife Investment Management's NxStage Medical Inc. position peaked at $873K in Q4 2018.
1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.

Based on MetLife Investment Management's 13F filing for Q1 2019, filed 15 May 2019.